Kevin Paul Baker Net Worth

What's Kevin Baker's mailing address?

Kevin's mailing address filed with the SEC is C/O FIVE PRIME THERAPEUTICS, INC., TWO CORPORATE DRIVE, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Five Prime Therapeutics Inc

Over the last 11 years, insiders at Five Prime Therapeutics Inc have traded over $158,392,438 worth of Five Prime Therapeutics Inc stock and bought 4,750,507 units worth $20,970,721 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... és Capital Partners Gp, L.L.C..... On average, Five Prime Therapeutics Inc executives and independent directors trade stock every 27 days with the average trade being worth of $6,730,346. The most recent stock trade was executed by Francis Willard Sarena on 11 December 2020, trading 22,000 units of FPRX stock currently worth $1,078,000.

What does Five Prime Therapeutics Inc do?

Five Prime Therapeutics Inc executives and stock owners

Five Prime Therapeutics Inc executives and other stock owners filed with the SEC include:

• Peder Jensen,
  Director
• Sheila Gujrathi,
  Director
• Mark Mcdade,
  Director
• Kapil Dhingra,
  Director
• Fred E Cohen,
  Director
• Garry A Nicholson,
  Director
• Franklin M Berger,
  Director
• Robert Steven Sikorski,
  SVP and Chief Medical Officer
• Luis Borges,
  SVP, Research
• Kevin Paul Baker,
  SVP, Development Sciences
• Marc Belsky,
  SVP and CFO
• R Lee Douglas,
  Director
• Francis Willard Sarena,
  Chief Strategy Officer
• Aron Marc Knickerbocker,
  President & CEO
• David V Smith,
  Executive Vice President & CFO
• Lewis T Williams,
  Director
• David White,
  See Remarks
• Carol Schafer,
  Director
• Partners L P/Ilbiotechnolog...,
  
• Bryan Irving,
  EVP, Chief Scientific Officer
• Capital Partners Gp, L.L.C....,
  
• Julie Hambleton,
  SVP & Chief Medical Officer
• William Michael Kavanaugh,
  SVP & Chief Scientific Officer
• Brian G Atwood,
  Director
• Lori Lyons Williams,
  Director
• Helen Louise Collins,
  EVP and Chief Medical Officer
• William R Ringo,
  Director
• Thomas Civik,
  President and CEO
• Partners L P/Ilbiotechnolog...,